In a pancreatic ductal adenocarcinoma cell model, CDK4/6 inhibition was associated with increased mTORC1 activity, which produces ATP accumulation at the mitochondrial level and induces drug resistance (25). This evidence concerns the gene CDK4 and pancreatic ductal adenocarcinoma.